Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis
- 6 May 2005
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 129 (4), 553-560
- https://doi.org/10.1111/j.1365-2141.2005.05490.x
Abstract
Myeloproliferative disorders (MPD) are reported in 25-65% of patients with splanchnic vein thrombosis (SVT). Diagnostic criteria for MPD have not been fully established in this context. Using clusters of abnormal megakaryocytes in bone marrow (BM) biopsy as a reference standard for Philadelphia negative MPD, we assessed the relevance of other criteria currently recommended for the diagnosis of MPD in SVT (128 consecutive SVT patients). First, usual criteria were compared with BM results: endogenous erythroid colony formation (EEC) was strongly correlated with BM results; splenomegaly, blood cell count, total red cell volume, erythropoietin level and cytogenetic were much less accurate. Then, patients were assigned to three groups according to the combination of BM and EEC findings (group I: both present; group II: both absent; group III: other patients); clinical presentation and outcome were compared in each group. At a mean follow-up of 6.09 +/- 6.6 years, progression to a severe form of MPD occurred in 7 of 31 group I patients (23%), in 1 of 34 group III patients (3%) and 0 of 63 group II patients. The combination of marked splenomegaly and platelet count >200 x 10(9)/l was restricted to groups I and III. In conclusion, in patients with SVT, BM findings and EEC allowed the diagnosis of MPD at risk of aggravation. Marked splenomegaly in association with platelet counts >200 x 10(9)/l constitute a simple index with high specificity but low sensitivity.Keywords
This publication has 36 references indexed in Scilit:
- Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factorsHepatology, 2000
- Should a platelet limit of 600 × 109/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stagesBritish Journal of Haematology, 1998
- Diagnostic and Differential Criteria of Essential Thrombocythemia and Reactive ThrombocytosisLeukemia & Lymphoma, 1996
- Bone Marrow Scintigraphy as a Useful Method for Estimating the Physiological Status of Bone Marrow and Spleen in Polycythaemia VeraLeukemia & Lymphoma, 1996
- Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in HaematologyBritish Journal of Haematology, 1995
- Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatmentBritish Journal of Haematology, 1992
- Hepatic and portal vein-thrombosis.BMJ, 1991
- Erythroid colony growth from peripheral blood and bone marrow in polycythaemia.Journal of Clinical Pathology, 1990
- Polycythemia and the budd-chiari syndrome: Study of serum erythropoietin and bone marrow erythroid progenitorsHepatology, 1985
- FORMES FRUSTES IN MYELOPROLIFERATIVE DISORDERSThe Lancet, 1982